Marie-France Langlois

Financement

• Subvention. Bone and Muscle Health Following Sleeve Gastrectomy in Men, Premenopausal and Postmenopausal Women. Canadian Institutes of Health Research (Ottawa, Canada). 875 925 $. (2022-2027).
  Numéro de subvention : 202109PJT. Voir plus
• Subvention. The Fit-for-Fertility Multicenter Randomized-Controlled Trial: Improving Reproductive, Maternal and Neonatal Outcomes in Women with Obesity and Infertility. Canadian Institutes of Health Research (Ottawa, Canada). 781 023 $. (2018-2022).
  Numéro de subvention : 201709PJT. Voir plus
• Subvention. Facteurs associés à la gêne psychosociale causée par le surplus de peau suite à une perte de poids massive. Social Sciences and Humanities Research Council (Ottawa, Canada). 69 991 $. (2018-2020).
  Numéro de subvention : grant.8666295. Voir plus
• Subvention. Patient-Oriented Clinical Practice Guidelines for the Management of Obesity in Adults. Canadian Institutes of Health Research (Ottawa, Canada). 40 000 $. (2018-2019).
  Numéro de subvention : 201711PEH. Voir plus
• Subvention. Optimisation de la prise en charge en activite physique lors de la chirurgie bariatrique : strategie de recherche axee sur le patient. Canadian Institutes of Health Research (Ottawa, Canada). 19 867 $. (2017-2018).
  Numéro de subvention : 201708PCS. Voir plus
• Subvention. Dissemination activity : Integration of prevention and management of cardio-metabolic chronic diseases. Canadian Institutes of Health Research (Ottawa, Canada). 20 000 $. (2015).
  Numéro de subvention : 201408PCS. Voir plus
• Subvention. Regulation of obesity by inflammatory cytokines. Canadian Institutes of Health Research (Ottawa, Canada). 720 623 $. (2014-2019).
  Numéro de subvention : 201403MOP. Voir plus
• Subvention. Effets d'un programme preoperatoire d'activite physique supervisee sur l'etat de sante des personnes obeses en attente d'une chirurgie bariatrique. Canadian Institutes of Health Research (Ottawa, Canada). 100 000 $. (2013-2014).
  Numéro de subvention : 201303OPB. Voir plus
• Subvention. Le traitement de l'obesite : mythes et realites. Canadian Institutes of Health Research (Ottawa, Canada). 3 000 $. (2013-2014).
  Numéro de subvention : 201305SCI. Voir plus
• Subvention. Impact de l'activite physique reguliere sur les comorbidites, la forme physique, la qualite de vie et les complications peri-operatoires chez les personnes avec obesite severe. Canadian Institutes of Health Research (Ottawa, Canada). 88 222 $. (2012-2013).
  Numéro de subvention : 201204KRS. Voir plus
• Subvention. National Collaboration on Obesity Management in Primary Care. Canadian Institutes of Health Research (Ottawa, Canada). 25 000 $. (2011-2012).
  Numéro de subvention : 201106MCO. Voir plus
• Subvention. Prise en charge de l'obésité : des mécanismes moléculaires à l'organisation des soins de santé. Fonds de Recherche du Québec - Santé (Montreal, Canada). 180 000 $. (2011-2015).
  Numéro de subvention : 22499. Voir plus
• Subvention. Evaluation of clinical outcomes and costs of a transferable interdisciplinary lifestyle intervention pre-and per-pregnancy in obese infertile women. Canadian Institutes of Health Research (Ottawa, Canada). 345 500 $. (2011-2014).
  Numéro de subvention : 201011PHE. Voir plus
• Subvention. Prevention et gestion integree du diabete et de l'obesite CSSS-CHUS. Canadian Institutes of Health Research (Ottawa, Canada). 11 645 $. (2011-2012).
  Numéro de subvention : 201010PLH. Voir plus
• Subvention. Networking and partnership development meeting for management of obesity in infertile women. Canadian Institutes of Health Research (Ottawa, Canada). 15 000 $. (2010-2011).
  Numéro de subvention : 201002MPS. Voir plus
• Subvention. Integrated medical and surgical approach for the treatment of severe or complicated obesity. Canadian Institutes of Health Research (Ottawa, Canada). 350 000 $. (2010-2013).
  Numéro de subvention : 200911PHE. Voir plus
• Subvention. Integrated service platform for assessment of emerging environmental reprotoxins: PINE team (Plateforme INtegrative en Environnement). Canadian Institutes of Health Research (Ottawa, Canada). 8 439 $. (2009-2010).
  Numéro de subvention : 200811RHL. Voir plus
• Subvention. Impact of life time body composition on mortality and chronic conditions risk in the elderly. Canadian Institutes of Health Research (Ottawa, Canada). 118 333 $. (2009-2011).
  Numéro de subvention : 200802SIB. Voir plus
• Subvention. Networking/partnership development meeting for cost-effective management of obesity in primary care. Canadian Institutes of Health Research (Ottawa, Canada). 25 000 $. (2009).
  Numéro de subvention : 200810MPS. Voir plus
• Subvention. Impact of an integrated obesity management system on patients' care. Canadian Institutes of Health Research (Ottawa, Canada). 150 000 $. (2008-2011).
  Numéro de subvention : 200803PHE. Voir plus
• Subvention. Régulation du métabolisme et obésité: des mécanismes moléculaires à l'organisation des soins de santé. Fonds de Recherche du Québec - Santé (Montreal, Canada). 38 534 $. (2007-2011).
  Numéro de subvention : 12169. Voir plus
• Subvention. Environmental exposure to organohalogens during pregnancy and in utero : Study of biomarkers of thyroid disruption. Canadian Institutes of Health Research (Ottawa, Canada). 68 430 $. (2007).
  Numéro de subvention : 200609IHD. Voir plus
• Subvention. Le role de RanBPM dans l'ubiquitination et la stabilite des recepteurs nucleaires des hormones thyroidiennes. Canadian Institutes of Health Research (Ottawa, Canada). 17 500 $. (2006-2007).
  Numéro de subvention : 200602CGM. Voir plus
• Subvention. Integrated obesity care management system/ Programme integre de prise en charge de l'obesite. Canadian Institutes of Health Research (Ottawa, Canada). 100 000 $. (2005-2008).
  Numéro de subvention : 200505PHE. Voir plus
• Subvention. Mechanisms of action of ranBPM, a novel coactivator for thyroid hormone receptors/ Mecanismes d'action de ranBPM, un nouveau coactivateur du recepteur des hormones thyroidiennes. Canadian Institutes of Health Research (Ottawa, Canada). 358 026 $. (2004-2007).
  Numéro de subvention : 200309MOP. Voir plus
• Subvention. The role of T3-receptors and their cofactors in thyroid hormone action. Canadian Institutes of Health Research (Ottawa, Canada). 36 916 $. (2002-2003).
  Numéro de subvention : 200109MOP. Voir plus
• Subvention. The role of thyroid hormone receptors and their cofactors in negative regulation by T3. Canadian Institutes of Health Research (Ottawa, Canada). 193 536 $. (1999-2002).
  Numéro de subvention : 199809MOP. Voir plus

Publications

Articles

• St-Laurent, A., Belan, M., Jean-Denis, F., Langlois, M.-F., Pesant, M.-H., Carranza-Mamane, B., Duval, K., Morisset, A.-S., Baillargeon, J.-P. (2025). An interdisciplinary intervention improves lifestyle behaviours in women living with obesity and subfertility: A secondary analysis of a randomized controlled trial. Clinical Nutrition Espen. DOI
• Baillot, A., Asselin, M., Bernard, P., Lapointe, J., Bond, D.S., Romain, A.J., Garneau, P.Y., Biertho, L., Tchernof, A., Blackburn, P., Langlois, M., Brunet, J. (2025). Correction: Acceptability and Feasibility of the Telehealth Bariatric Behavioral Intervention to Increase Physical Activity Before Bariatric Surgery: A Single-Case Experimental Study (Part I) (Obesity Surgery, (2024), 34, 5, (1639-1652), 10.1007/s11695-024-07161-0). Obesity Surgery. DOI
• Baillot, A., Asselin, M., Bernard, P., Lapointe, J., Bond, D.S., Romain, A.J., Garneau, P.Y., Biertho, L., Tchernof, A., Blackburn, P., Langlois, M.-F., Brunet, J. (2024). Acceptability and Feasibility of the Telehealth Bariatric Behavioral Intervention to Increase Physical Activity Before Bariatric Surgery: A Single-Case Experimental Study (Part I). Obesity Surgery. DOI
• Lanthier, L., Langlois, M.-F., Plourde, M.-É., Cauchon, M. (2024). Among adults with cardiovascular disease and BMI ≥ 27 kg/m2 but no diabetes, does semaglutide lower risk of cardiovascular mortality, myocardial infarction, or stroke when compared with placebo, and is it safe?,Chez les adultes avec maladie cardiovasculaire et IMC ≥ 27 kg/m2, mais sans diabète, est-ce que le sémaglutide diminue le risque de mortalité cardiovasculaire, d'infarctus du myocarde ou d'AVC comparativement au placebo tout en étant sécuritaire ?. Revue De Medecine Interne. DOI
• Marceau, M., Vachon Lachiver, É., Lambert, D., Daoust, J., Dion, V., Langlois, M.-F., McConnell, M., Thomas, A., St-Onge, C. (2024). Assessment Practices in Continuing Professional Development Activities in Health Professions: A Scoping Review. Journal of Continuing Education in the Health Professions. DOI
• Arbour, G., Legendre, M., Langlois, M.-F., Bégin, C. (2024). Novel Guided Self-Help for the treatment of Binge Eating Disorder: Feasibility, Acceptability, and Preliminary Efficacy. Canadian Journal of Dietetic Practice and Research. DOI
• Deanfield, J., Verma, S., Scirica, B.M., Plutzky, J., Emerson, S.S., Ryan, D., Lingvay, I., Colhoun, H.M., Kosiborod, M.N., Hovingh, G.K., Hardt-Lindberg, S., Frenkel, O., Weeke, P.E., Rasmussen, S., Goudev, A., Lang, C.C., Urina-Triana, M., Pietilä, M., Lincoff, A.M., ... Tornøe, C.W. (2024). Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial. Lancet. DOI
• Baillot, A., Brunet, J., Lemelin, L., Gabriel, S.A., Langlois, M.-F., Tchernof, A., Biertho, L., Rabasa-Lhoret, R., Garneau, P.Y., Aimé, A., Bouchard, S., Romain, A.J., Bernard, P. (2023). Factors Associated with Excess Skin After Bariatric Surgery: a Mixed-Method Study. Obesity Surgery. DOI
• Baillot, A., St-Pierre, M., Lapointe, J., Bernard, P., Bond, D., Romain, A.J., Garneau, P.Y., Biertho, L., Tchernof, A., Blackburn, P., Langlois, M.-F., Brunet, J. (2022). Acceptability and Feasibility of the Telehealth Bariatric Behavioral Intervention to Increase Physical Activity: Protocol for a Single-Case Experimental Study. Jmir Research Protocols. DOI
• Breuker, C., Teasdale, J., Mallet, L., Ricard, G., Turcotte, J.-P., Gosselin, S., Langlois, M.-F., Imbeault, P., Breton, M., Couturier, Y., Sirois, C., Cossette, B. (2022). Communication between hospitals, Family Medicine Groups and community pharmacists during transitions of care interventions. Research in Social and Administrative Pharmacy. DOI
• Cossette, B., Ricard, G., Poirier, R., Gosselin, S., Langlois, M.-F., Imbeault, P., Breton, M., Couturier, Y., Sirois, C., Lessard-Beaudoin, M., Rodrigue, C., Teasdale, J., Turcotte, J.-P., Mallet, L. (2022). Pharmacist-led transitions of care between hospitals, primary care clinics, and community pharmacies. Journal of the American Geriatrics Society. DOI
• Belan, M., Gélinas, M., Carranza-Mamane, B., Langlois, M.-F., Morisset, A.-S., Ruchat, S.-M., Lavoie, K., Adamo, K., Poder, T., Gallagher, F., Pesant, M.-H., Jean-Denis, F., Baillargeon, J.-P. (2022). Protocol of the Fit-For-Fertility study: a multicentre randomised controlled trial assessing a lifestyle programme targeting women with obesity and infertility. BMJ Open. DOI
• Marcotte-Chénard, A., Tremblay, D., Mony, M.-M., Boulay, P., Brochu, M., Morais, J.A., Dionne, I.J., Langlois, M.-F., Mampuya, W.M., Tessier, D.M., Boulé, N.G., Riesco, E. (2021). Acute and Chronic Effects of Low-Volume High-Intensity Interval Training Compared to Moderate-Intensity Continuous Training on Glycemic Control and Body Composition in Older Women with Type 2 Diabetes. Obesities. DOI
• Carbonneau, E., Lamarche, B., Provencher, V., Desroches, S., Robitaille, J., Vohl, M.-C., Bégin, C., Bélanger, M., Couillard, C., Pelletier, L., Bouchard, L., Houle, J., Langlois, M.-F., Corneau, L., Lemieux, S. (2021). Associations Between Nutrition Knowledge and Overall Diet Quality: The Moderating Role of Sociodemographic Characteristics—Results From the PREDISE Study. American Journal of Health Promotion. DOI
• Lanthier, L., Langlois, M.-F., Plourde, M.-É., Cauchon, M. (2021). For obese patients or for patients who are overweight and have an associated comorbidity, how safe and effective is semaglutide as compared with placebo as an adjunct to lifestyle intervention for reducing body weight and other related end points?,Chez les sujets avec obésité ou embonpoint associé à une comorbidité, quelle est l'efficacité et la sécurité du sémaglutide combiné à une intervention sur le mode de vie pour réduire le poids corporel et d'autres paramètres associés comparativement au placebo ?. Revue De Medecine Interne. DOI
• Sirard, S., Nault, V., Langlois, M.-F., Perron, J., Valiquette, L. (2021). Impact of a hospital-wide computerised approach to optimise the quality of antimicrobial prescriptions in patients with severe obesity: a quasi-experimental study. BMC Infectious Diseases. DOI
• Carbonneau, E., Pelletier, L., Bégin, C., Lamarche, B., Bélanger, M., Provencher, V., Desroches, S., Robitaille, J., Vohl, M.-C., Couillard, C., Bouchard, L., Houle, J., Langlois, M.-F., Rabasa-Lhoret, R., Corneau, L., Lemieux, S. (2021). Individuals with self-determined motivation for eating have better overall diet quality: Results from the PREDISE study. Appetite. DOI
• Carbonneau, E., Lamarche, B., Provencher, V., Desroches, S., Robitaille, J., Vohl, M.-C., Bégin, C., Bélanger, M., Couillard, C., Pelletier, L., Houle, J., Langlois, M.-F., Rabasa-Lhoret, R., Corneau, L., Lemieux, S. (2021). Liking for foods high in salt and fat is associated with a lower diet quality but liking for foods high in sugar is not – Results from the PREDISE study. Food Quality and Preference. DOI
• Marcotte-Chénard, A., Tremblay, D., Mony, M.-M., Brochu, M., Dionne, I.J., Langlois, M.F., Mampuya, W., Morais, J., Tessier, D., Riesco, E. (2021). Low-volume walking HIIT: Efficient strategy to improve physical capacity and reduce the risk of cardiovascular disease in older women with type 2 diabetes. Diabetes and Metabolic Syndrome Clinical Research and Reviews. DOI
• Cossette, B., Ricard, G., Poirier, R., Gosselin, S., Langlois, M.-F., Breton, M., Sirois, C., Rodrigue, C., Lessard-Beaudoin, M., Teasdale, J., Piché, B., Khalilipalandi, S., Trottier, L., Mallet, L. (2021). Pharmacist-led transitions of care for older adults at risk of drug-related problems: A feasibility study. Research in Social and Administrative Pharmacy. DOI
• Rakotoarivelo, V., Variya, B., Langlois, M.-F., Ramanathan, S. (2020). Chemokines in human obesity. Cytokine. DOI
• Baillargeon, J.-P., St-Cyr-Tribble, D., Xhignesse, M., Brown, C., Carpentier, A.C., Fortin, M., Grant, A., Simoneau-Roy, J., Langlois, M.-F. (2020). Impact of an educational intervention combining clinical obesity preceptorship with electronic networking tools on primary care professionals: a prospective study. BMC Medical Education. DOI
• Sirard, S., Chakra, C.N.A., Langlois, M.-F., Perron, J., Carignan, A., Valiquette, L. (2020). Is antimicrobial dosing adjustment associated with better outcomes in patients with severe obesity and bloodstream infections? An exploratory study. Antibiotics. DOI
• Baker, B.H., Wu, H., Laue, H.E., Boivin, A., Gillet, V., Langlois, M.-F., Bellenger, J.-P., Baccarelli, A.A., Takser, L. (2020). Methylparaben in meconium and risk of maternal thyroid dysfunction, adverse birth outcomes, and Attention-Deficit Hyperactivity Disorder (ADHD). Environment International. DOI
• Wharton, S., Lau, D.C.W., Vallis, M., Sharma, A.M., Biertho, L., Campbell-Scherer, D., Adamo, K., Alberga, A., Bell, R., Boulé, N., Boyling, E., Brown, J., Calam, B., Clarke, C., Crowshoe, L., Divalentino, D., Forhan, M., Freedhoff, Y., Gagner, M., ... Wicklum, S. (2020). Obesity in adults: A clinical practice guideline. CMAJ. DOI
• Wharton, S., Lau, D.C.W., Vallis, M., Sharma, A.M., Biertho, L., CampbellScherer, D., Adamo, K., Alberga, A., Bell, R., Boulé, N., Boyling, E., Brown, J., Calam, B., Clarke, C., Crowshoe, L., Divalentino, D., Forhan, M., Freedhoff, Y., Gagner, M., ... Wicklum, S. (2020). Obesity in adults: A clinical practice guideline,L’obésité chez l’adulte: Ligne directrice de pratique clinique. CMAJ. DOI
• Harrison, S., Couillard, C., Robitaille, J., Vohl, M.-C., Bélanger, M., Desroches, S., Provencher, V., Rabasa-Lhoret, R., Bouchard, L., Langlois, M.-F., Houle, J., Lemieux, S., Lamarche, B. (2019). Assessment of the American Heart Association's “Life's simple 7” score in French-speaking adults from Québec. Nutrition Metabolism and Cardiovascular Diseases. DOI
• Wiviott, S.D., Raz, I., Bonaca, M.P., Mosenzon, O., Kato, E.T., Cahn, A., Silverman, M.G., Zelniker, T.A., Kuder, J.F., Murphy, S.A., Bhatt, D.L., Leiter, L.A., McGuire, D.K., Wilding, J.P.H., Ruff, C.T., Nilsson, G.I., Fredriksson, M., Johansson, P.A., Langkilde, A.M., ... Nguyễn, V. (2019). Dapagliflozin and cardiovascular outcomes in type 2 diabetes. New England Journal of Medicine. DOI
• Gerstein, H.C., Colhoun, H.M., Dagenais, G.R., Diaz, R., Lakshmanan, M., Pais, P., Probstfield, J., Riesmeyer, J.S., Riddle, M.C., Rydén, L., Xavier, D., Atisso, C.M., Dyal, L., Hall, S., Rao-Melacini, P., Wong, G., Avezum, A., Basile, J., Chung, N., ... Zigrang, W. (2019). Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial. Lancet. DOI
• Gerstein, H.C., Colhoun, H.M., Dagenais, G.R., Diaz, R., Lakshmanan, M., Pais, P., Probstfield, J., Botros, F.T., Riddle, M.C., Rydén, L., Xavier, D., Atisso, C.M., Dyal, L., Hall, S., Rao-Melacini, P., Wong, G., Avezum, A., Basile, J., Chung, N., ... Zigrang, W. (2019). Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial. Lancet. DOI
• Belan, M., Carranza-Mamane, B., Pesant, M.H., AinMelk, Y., Duval, K., Jean-Denis, F., Langlois, M.F., Baillargeon, J.P. (2019). Male partners of subfertile couples in which the spouse is obese display adverse weight and lifestyle associated with reduced sperm quality. Obesity Research and Clinical Practice. DOI
• Sharma, A.M., Bélanger, A., Carson, V., Krah, J., Langlois, M.-F., Lawlor, D., Lepage, S., Liu, A., Macklin, D.A., MacKay, N., Pakseresht, A., Pedersen, S.D., Ramos Salas, X., Vallis, M. (2019). Perceptions of barriers to effective obesity management in Canada: Results from the ACTION study. Clinical Obesity. DOI
• Carbonneau, E., Lamarche, B., Robitaille, J., Provencher, V., Desroches, S., Vohl, M.-C., Bégin, C., Bélanger, M., Couillard, C., Pelletier, L., Bouchard, L., Houle, J., Langlois, M.-F., Corneau, L., Lemieux, S. (2019). Social support, but not perceived food environment, is associated with diet quality in french-speaking canadians from the PREDISE study. Nutrients. DOI
• Rakotoarivelo, V., Lacraz, G., Mayhue, M., Brown, C., Rottembourg, D., Fradette, J., Ilangumaran, S., Menendez, A., Langlois, M.-F., Ramanathan, S. (2018). Corrigendum to “Inflammatory cytokine profiles in visceral and subcutaneous adipose tissues of obese patients undergoing bariatric surgery reveal lack of correlation with obesity or diabetes” (EBioMedicine (2018) 30 (237–247), (S2352396418300884), (10.1016/j.ebiom.2018.03.004)). Ebiomedicine. DOI
• Baillot, A., Vallée, C.-A., Mampuya, W.M., Dionne, I.J., Comeau, E., Méziat-Burdin, A., Langlois, M.-F. (2018). Effects of a Pre-surgery Supervised Exercise Training 1 Year After Bariatric Surgery: a Randomized Controlled Study. Obesity Surgery. DOI
• Rakotoarivelo, V., Variya, B., Ilangumaran, S., Langlois, M.-F., Ramanathan, S. (2018). Inflammation in human adipose tissues–Shades of gray, rather than white and brown. Cytokine and Growth Factor Reviews. DOI
• Rakotoarivelo, V., Lacraz, G., Mayhue, M., Brown, C., Rottembourg, D., Fradette, J., Ilangumaran, S., Menendez, A., Langlois, M.-F., Ramanathan, S. (2018). Inflammatory Cytokine Profiles in Visceral and Subcutaneous Adipose Tissues of Obese Patients Undergoing Bariatric Surgery Reveal Lack of Correlation With Obesity or Diabetes. Ebiomedicine. DOI
• Baillot, A., Baillargeon, J.-P., Pare, A., Poder, T.G., Brown, C., Langlois, M.-F. (2018). Physical activity assessment and counseling in Quebec family medicine groups. Canadian Family Physician.
• Brassard, D., Laramée, C., Corneau, L., Bégin, C., Bélanger, M., Bouchard, L., Couillard, C., Desroches, S., Houle, J., Langlois, M.-F., Provencher, V., Rabasa-Lhoret, R., Vohl, M.-C., Robitaille, J., Lemieux, S., Lamarche, B. (2018). Poor Adherence to Dietary Guidelines Among French-Speaking Adults in the Province of Quebec, Canada: The PREDISE Study. Canadian Journal of Cardiology. DOI
• Lampron-Goulet, É., Gagnon, F., Langlois, M.-F. (2017). Association between consumption of private well water contaminated by low levels of arsenic and dysglycemia in a rural region of Quebec, Canada. Environmental Research. DOI
• Chouiali, A., Mallet, P.-L., Fink, G., Biron, S., Langlois, M.-F. (2017). Comparison of two methods for measuring 25-OH vitamin D in the follow-up of patients after bilio-pancreatic diversion bariatric surgery. Clinical Biochemistry. DOI
• Baillot, A., Boissy, P., Tousignant, M., Langlois, M.-F. (2017). Feasibility and effect of in-home physical exercise training delivered via telehealth before bariatric surgery. Journal of Telemedicine and Telecare. DOI
• Baillot, A., Brais-Dussault, E., Bastin, A., Cyr, C., Brunet, J., Aimé, A., Romain, A.J., Langlois, M.-F., Bouchard, S., Tchernof, A., Rabasa-Lhoret, R., Garneau, P.-Y., Bernard, P. (2017). What Is Known About the Correlates and Impact of Excess Skin After Bariatric Surgery: a Scoping Review. Obesity Surgery. DOI
• Gerstein, H.C., Bosch, J., Dagenais, G.R., Díaz, R., Jung, H., Maggioni, A.P., Pogue, J., Probstfield, J., Ramachandran, A., Riddle, M.C., Rydén, L.E., Yusuf, S., Richardson, L., Diaz, R., Johnston, P., Vige, R., Birkeland, K., Budaj, A., Cardona, E., ... Urbaneja, H. (2016). Cardiovascular and other outcomes postintervention with insulin glargine and omega-3 fatty acids (ORIGINALE). Diabetes Care. DOI
• Lacraz, G., Rakotoarivelo, V., Labbé, S.M., Vernier, M., Noll, C., Mayhue, M., Stankova, J., Schwertani, A., Grenier, G., Carpentier, A., Richard, D., Ferbeyre, G., Fradette, J., Rola-Pleszczynski, M., Menendez, A., Langlois, M.-F., Ilangumaran, S., Ramanathan, S. (2016). Deficiency of interleukin-15 confers resistance to obesity by diminishing inflammation and enhancing the thermogenic function of adipose tissues. Plos One. DOI
• Baillargeon, J.-P., St-Cyr-Tribble, D., Xhignesse, M., Grant, A., Brown, C., Poder, T.G., Langlois, M.-F. (2016). Erratum to: Impact of an integrated obesity management system on patient's care - research protocol [BMC Obesity, 3, 23 (2016)] DOI: 10.1186/s40608-016-0101-9. BMC Obesity. DOI
• Baillot, A., Mampuya, W.M., Dionne, I.J., Comeau, E., Méziat-Burdin, A., Langlois, M.-F. (2016). Impacts of Supervised Exercise Training in Addition to Interdisciplinary Lifestyle Management in Subjects Awaiting Bariatric Surgery: a Randomized Controlled Study. Obesity Surgery. DOI
• Gagnon, F., Lampron-Goulet, E., Normandin, L., Langlois, M.-F. (2016). Measurements of Arsenic in the Urine and Nails of Individuals Exposed to Low Concentrations of Arsenic in Drinking Water From Private Wells in a Rural Region of Québec, Canada. Journal of Environmental Health.
• Blouin, C., Hamel, D., Vandal, N., Barry, A.D., Lo, E., Lacroix, G., Laguë, J., Langlois, M.-F., Martel, S., Michaud, P.-C., Pérusse, L. (2016). The economic consequences of obesity and overweight among adults in Quebec. Canadian Journal of Public Health. DOI
• Baillot, A., Romain, A.J., Boisvert-Vigneault, K., Audet, M., Baillargeon, J.P., Dionne, I.J., Valiquette, L., Chakra, C.N.A., Avignon, A., Langlois, M.-F. (2015). Effects of lifestyle interventions that include a physical activity component in class II and III obese individuals: A systematic review. Plos One. DOI
• Baillot, A., Baillargeon, J.-P., Brown, C., Poder, T., Langlois, M.-F. (2015). Erratum: The 6-min walk test reflects functional capacity in primary care and obese patients (International Journal of Sports Medicine (2015) 36:06 (503-509) DOI: 10.1055/s-0034-1398533). International Journal of Sports Medicine. DOI
• Baillot, A., Baillargeon, J.-P., Brown, C., Langlois, M.-F. (2015). The 6-min walk test reflects functional capacity in primary care and obese patients. International Journal of Sports Medicine. DOI
• Duval, K., Langlois, M.-F., Carranza-Mamane, B., Pesant, M.-H., Hivert, M.-F., Poder, T.G., Lavoie, H.B., Ainmelk, Y., Tribble, D.S.-C., Laredo, S., Greenblatt, E., Sagle, M., Waddell, G., Belisle, S., Riverin, D., Jean-Denis, F., Belan, M., Baillargeon, J.-P. (2015). The Obesity-Fertility Protocol: A randomized controlled trial assessing clinical outcomes and costs of a transferable interdisciplinary lifestyle intervention, before and during pregnancy, in obese infertile women. BMC Obesity. DOI
• Thibault, V., Morisset, A.-S., Brown, C., Carpentier, A.C., Baillargeon, J.-P., Langlois, M.-F., Gagnon, C. (2015). The increase in serum 25-hydroxyvitamin D following weight loss does not contribute to the improvement in insulin sensitivity, insulin secretion and β-cell function. British Journal of Nutrition. DOI
• Lacerte, G., Langlois, M.-F., Doyon, M., Brown, C., Carpentier, A.C., Hivert, M.-F. (2014). Differential impact of changes in adiposity distribution on insulin resistance and adiponectin variations over 4 years in normal weight young adults. Hormone and Metabolic Research. DOI
• Wadzinski, T.L., Geromini, K., Brewer, J.M., Bansal, R., Abdelouahab, N., Langlois, M.-F., Takser, L., Zoeller, R.T. (2014). Endocrine disruption in human placenta: Expression of the dioxin-inducible enzyme, Cyp1a1, is correlated with that of thyroid hormone-regulated genes. Journal of Clinical Endocrinology and Metabolism. DOI
• Baillargeon, J.-P., St-Cyr-Tribble, D., Xhignesse, M., Grant, A., Brown, C., Langlois, M.-F. (2014). Impact of an integrated obesity management system on patient's care - research protocol. BMC Obesity. DOI
• Baillot, A., Audet, M., Baillargeon, J.P., Dionne, I.J., Valiquette, L., Rosa-Fortin, M.M., Abou Chakra, C.N., Comeau, E., Langlois, M.F. (2014). Impact of physical activity and fitness in class II and III obese individuals: A systematic review. Obesity Reviews. DOI
• Labbé, S.M., Noll, C., Grenier-Larouche, T., Kunach, M., Bouffard, L., Phoenix, S., Guérin, B., Baillargeon, J.-P., Langlois, M.-F., Turcotte, E.E., Carpentier, A.C. (2014). Improved cardiac function and dietary fatty acid metabolism after modest weight loss in subjects with impaired glucose tolerance. American Journal of Physiology Endocrinology and Metabolism. DOI
• Baillot, A., Pelletier, C., Dunbar, P., Geiss, L., Johnson, J.A., Leiter, L.A., Langlois, M.-F. (2014). Profile of adults with type 2 diabetes and uptake of clinical care best practices: Results from the 2011 Survey on Living with Chronic Diseases in Canada - Diabetes component. Diabetes Research and Clinical Practice. DOI
• Rosa Fortin, M.-M., Brown, C., Ball, G.D., Chanoine, J.-P., Langlois, M.-F. (2014). Weight management in Canada: An environmental scan of health services for adults with obesity. BMC Health Services Research. DOI
• Abdelouahab, N., Langlois, M.-F., Lavoie, L., Corbin, F., Pasquier, J.-C., Takser, L. (2013). Abdelouahab et al. Respond to "maternal PBDEs and thyroid hormones". American Journal of Epidemiology. DOI
• Forget, G., Doyon, M., Lacerte, G., Labonté, M., Brown, C., Carpentier, A.C., Langlois, M.-F., Hivert, M.-F. (2013). Adoption of American Heart Association 2020 Ideal Healthy Diet Recommendations Prevents Weight Gain in Young Adults. Journal of the Academy of Nutrition and Dietetics. DOI
• Shum, M., Pinard, S., Guimond, M.-O., Labbé, S.M., Roberge, C., Baillargeon, J.-P., Langlois, M.-F., Alterman, M., Wallinder, C., Hallberg, A., Carpentier, A.C., Gallo-Payet, N. (2013). Angiotensin II type 2 receptor promotes adipocyte differentiation and restores adipocyte size in high-fat/high-fructose diet-induced insulin resistance in rats. American Journal of Physiology Endocrinology and Metabolism. DOI
• Agborsangaya, C.B., Gee, M.E., Johnson, S.T., Dunbar, P., Langlois, M.-F., Leiter, L.A., Pelletier, C., Johnson, J.A. (2013). Determinants of lifestyle behavior in type 2 diabetes: Results of the 2011 cross-sectional survey on living with chronic diseases in Canada. BMC Public Health. DOI
• Baillot, A., Mampuya, W.M., Comeau, E., Méziat-Burdin, A., Langlois, M.F. (2013). Feasibility and impacts of supervised exercise training in subjects with obesity awaiting bariatric surgery: A pilot study. Obesity Surgery. DOI
• Baillot, A., Asselin, M., Comeau, E., Méziat-Burdin, A., Langlois, M.-F. (2013). Impact of excess skin from massive weight loss on the practice of physical activity in women. Obesity Surgery. DOI
• Allard, C., Doyon, M., Brown, C., Carpentier, A.C., Langlois, M.-F., Hivert, M.-F. (2013). Lower leptin levels are associated with higher risk of weight gain over 2 years in healthy young adults. Applied Physiology Nutrition and Metabolism. DOI
• Abdelouahab, N., Langlois, M.-F., Lavoie, L., Corbin, F., Pasquier, J.-C., Takser, L. (2013). Maternal and cord-blood thyroid hormone levels and exposure to polybrominated diphenyl ethers and polychlorinated biphenyls during early pregnancy. American Journal of Epidemiology. DOI
• Bouchard, D.R., Langlois, M.-F., Boisvert-Vigneault, K., Farand, P., Paulin, M., Baillargeon, J.-P. (2013). Pilot study: Can older inactive adults learn how to reach the required intensity of physical activity guideline?. Clinical Interventions in Aging. DOI
• Bouchard, D.R., Porneala, B., Janssen, I., Langlois, M.-F., Baillargeon, J.-P., Fox, C.S., Meigs, J.B., D'Agostino Sr., R.B., Pencina, M., Hivert, M.-F. (2013). Risk of type 2 diabetes and cumulative excess weight exposure in the Framingham Offspring Study. Journal of Diabetes and Its Complications. DOI
• Agborsangaya, C.B., Robitaille, C., Dunbar, P., Langlois, M.-F., Leiter, L.A., Dai, S., Pelletier, C., Johnson, J.A. (2013). Self-monitoring of blood glucose in type 2 diabetes: Results of the 2011 survey on living with chronic diseases in canada. Health Reports.
• Bouchard, D.R., Baillargeon, J.-P., Langlois, M.-F. (2013). The Independent Effect of Age Groups on the Effectiveness of Lifestyle Intervention. Current Obesity Reports. DOI
• Castellano, C.-A., Laurin, D., Langlois, M.-F., Fortier, M., Tessier, D., Gaudreau, P., Ferland, G., Payette, H., Lorrain, D., Cunnane, S.C. (2013). Thyroid function and cognition in the euthyroid elderly: A case-control study embedded in quebec longitudinal study - nuage. Psychoneuroendocrinology. DOI
• Gallo-Payet, N., Shum, M., Baillargeon, J.-P., Langlois, M.-F., Wallinder, C., Alterman, M., Hallberg, A., Carpentier, A.C. (2012). AT2 receptor agonists: Exploiting the beneficial Arm of Ang II signaling. Current Hypertension Reviews. DOI
• Bouchard, D.R., Langlois, M.-F., Domingue, M.-E., Brown, C., Lebrun, V., Baillargeon, J.-P. (2012). Age differences in expectations and readiness regarding lifestyle modifications in individuals at high risk of diabetes. Archives of Physical Medicine and Rehabilitation. DOI
• Gerstein, H.C., Bosch, J., Dagenais, G.R., Díaz, R., Jung, H., Maggioni, A.P., Pogue, J., Probstfield, J., Ramachandran, A., Riddle, M.C., Rydén, L.E., Yusuf, S., Richardson, L., Diaz, R., Johnston, P., Vige, R., Birkeland, K., Budaj, A., Cardona, E., ... Urbaneja, H. (2012). Basal insulin and cardiovascular and other outcomes in dysglycemia. New England Journal of Medicine. DOI
• Bouchard, D.R., Baillargeon, J.-P., Gagnon, C., Brown, C., Langlois, M.-F. (2012). Impact of health professionals' contact frequency on response to a lifestyle intervention with individuals at high risk for diabetes. Diabetes Research and Clinical Practice. DOI
• Bosch, J., Gerstein, H.C., Dagenais, G.R., Díaz, R., Dyal, L., Jung, H., Maggiono, A.P., Probstfield, J., Ramachandran, A., Riddle, M.C., Rydén, L.E., Yusuf, S., Richardson, L., Diaz, R., Johnston, P., Vige, R., Birkeland, K., Budaj, A., Cardona, E., ... Urbaneja, H. (2012). N-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. New England Journal of Medicine. DOI
• Gagnon, C., Brown, C., Couture, C., Kamga-Ngande, C.N., Hivert, M.F., Baillargeon, J.P., Carpentier, A.C., Langlois, M.F. (2011). A cost-effective moderate-intensity interdisciplinary weight-management programme for individuals with prediabetes. Diabetes and Metabolism. DOI
• Brunelle, M., Fayad, T., Langlois, M.-F. (2011). Degradation of thyroid hormone receptor beta 1: Existence of stable and unstable forms. Thyroid. DOI
• Suvorov, A., Bissonnette, C., Takser, L., Langlois, M.-F. (2011). Does 2,2',4,4'-tetrabromodiphenyl ether interact directly with thyroid receptor?. Journal of Applied Toxicology. DOI
• Langlois, F., Langlois, M.-F., Carpentier, A.C., Brown, C., Lemieux, S., Hivert, M.-F. (2011). Ghrelin levels are associated with hunger as measured by the Three-Factor Eating Questionnaire in healthy young adults. Physiology and Behavior. DOI
• Bouchard, D.R., Langlois, M.-F., Brochu, M., Dionne, I.J., Baillargeon, J.-P. (2011). Metabolically healthy obese women and functional capacity. Metabolic Syndrome and Related Disorders. DOI
• Gagnon, C., Ménard, J., Bourbonnais, A., Ardilouze, J.-L., Baillargeon, J.-P., Carpentier, A.C., Langlois, M.-F. (2010). Comparison of foot-to-foot and hand-to-foot bioelectrical impedance methods in a population with a wide range of body mass indices. Metabolic Syndrome and Related Disorders. DOI
• Kong, W., Langlois, M.-F., Kamga-Ngandé, C., Gagnon, C., Brown, C., Baillargeon, J.-P. (2010). Predictors of success to weight-loss intervention program in individuals at high risk for type 2 diabetes. Diabetes Research and Clinical Practice. DOI
• Kamga-Ngandé, C.N., Carpentier, A.C., Nadeau-Marcotte, F., Ardilouze, J.-L., Baillargeon, J.-P., Bellabarba, D., Houde, G., Langlois, M.-F. (2009). Effectiveness of a multidisciplinary program for management of obesity: The Unité d'Enseignement, de Traitement et de Recherche sur l'Obésité (UETRO) database study. Metabolic Syndrome and Related Disorders. DOI
• Beriault, K., Carpentier, A.C., Gagnon, C., Ménard, J., Baillargeon, J.-P., Ardilouze, J.-L., Langlois, M.-F. (2009). Reproducibility of the 6-minute walk test in obese adults. International Journal of Sports Medicine. DOI
• Abdelouahab, N., Suvorov, A., Pasquier, J.-C., Langlois, M.-F., Praud, J.-P., Takser, L. (2009). Thyroid disruption by low-dose BDE-47 in prenatally exposed lambs. Neonatology. DOI
• Gagnon, F., Lareau-Trudel, E., Bachand, M.-P., Hamel, C., Lapointe, V., Dubois, M.-F., Xhignesse, M., Langlois, M.-F. (2008). Management of thyroid dysfunction by primary care physicians of the Province of Quebec: A transversal study,Étude transversale sur l'approche thérapeutique des patients avec troubles thyroïdiens par les omnipraticiens du Québec. Annales D Endocrinologie. DOI
• Roberge, C., Carpentier, A.C., Langlois, M.-F., Baillargeon, J.-P., Ardilouze, J.-L., Maheux, P., Gallo-Payet, N. (2007). Adrenocortical dysregulation as a major player in insulin resistance and onset of obesity. American Journal of Physiology Endocrinology and Metabolism. DOI
• Baillargeon, J.-P., Carpentier, A., Donovan, D., Fortin, M., Grant, A., Simoneau-Roy, J., St-Cyr-Tribble, D., Xhignesse, M., Langlois, M.-F. (2007). Integrated obesity care management system -implementation and research protocol. BMC Health Services Research. DOI
• Leboeuf, R., Perron, P., Carpentier, A.C., Verreault, J., Langlois, M.-F. (2007). L-T3 preparation for whole-body scintigraphy: A randomized-controlled trial. Clinical Endocrinology. DOI
• Hivert, M.-F., Langlois, M.-F., Bérard, P., Cuerrier, J.-P., Carpentier, A.C. (2007). Prevention of weight gain in young adults through a seminar-based intervention program. International Journal of Obesity. DOI
• Poirier, M.-B., Brunelle, M., Langlois, M.-F. (2007). The effect of RanBPM on the regulation of the hypothalamic-pituitary axis by thyroid hormone receptors is isoform-specific. Biochemical and Biophysical Research Communications. DOI
• Hivert, M.-F., Langlois, M.-F., Carpentier, A.C. (2007). The entero-insular axis and adipose tissue-related factors in the prediction of weight gain in humans. International Journal of Obesity. DOI
• Poirier, M.-B., Laflamme, L., Langlois, M.-F. (2006). Identification and characterization of RanBPM, a novel coactivator of thyroid hormone receptors. Journal of Molecular Endocrinology. DOI
• Gagnon, F., Langlois, M.-F., Michaud, I., Gingras, S., Duchesne, J.-F., Lévesque, B. (2006). Spatio-temporal distribution of hypothyroidism in Quebec. Chronic Diseases in Canada.
• Leboeuf, R., Bénard, F., Langlois, M.-F. (2006). Thyroid cancer presenting as a PET incidentaloma in a patient with concomitant breast cancer metastases to the thyroid. Clinical Nuclear Medicine. DOI
• Poirier, M.-B., Hamann, G., Domingue, M.-E., Roy, M., Bardati, T., Langlois, M.-F. (2005). General receptor for phosphoinositides 1, a novel repressor of thyroid hormone receptor action that prevents deoxyribonucleic acid binding. Molecular Endocrinology. DOI
• Laflamme, L., Hamann, G., Messier, N., Maltais, S., Langlois, M.-F. (2002). RXR acts as a coregulator in the regulation of genes of the hypothalamo-pituitary axis by thyroid hormone receptors. Journal of Molecular Endocrinology. DOI
• Messier, N., Laflamme, L., Hamann, G., Langlois, M.F. (2001). In vitro effect of Triac on resistance to thyroid hormone receptor mutants: Potential basis for therapy. Molecular and Cellular Endocrinology. DOI
• Baillargeon, J.-P., Pek, B., Teijeira, J., Poisson, J., van Rossum, N., Langlois, M.-F. (2000). Combined surgery for coronary artery disease and pheochromocytoma. Canadian Journal of Anaesthesia. DOI
• Messier, N., Langlois, M.F. (2000). Triac regulation of transcription is T3 receptor isoform- and response element-specific. Molecular and Cellular Endocrinology. DOI
• Langlois, M.-F., Zanger, K., Monden, T., Safer, J.D., Hollenberg, A.N., Wondisford, F.E. (1997). A unique role of the β-2 thyroid hormone receptor isoform in negative regulation by thyroid hormone: Mapping of a novel amino-terminal domain important for ligand-independent activation. Journal of Biological Chemistry. DOI
• Langlois, M.F., Ardilouze, J.-L., Black, R., Rioux, A., Bellabarba, D. (1997). Abnormal response of growth hormone to oral glucose tolerance test in obesity,Reponse anormale de l'hormone de croissance au cours de l'hyperglycemie provoquee orale chez le sujet obese. Annales D Endocrinologie.
• Safer, J.D., Langlois, M.F., Cohen, R., Monden, T., John-Hope, D., Madura, J., Hollenberg, A.N., Wondisford, F.E. (1997). Isoform variable action among thyroid hormone receptor mutants provides insight into pituitary resistance to thyroid hormone. Molecular Endocrinology. DOI
• Langlois, M.-F., Lamarche, J.B., Bellabarba, D. (1996). Long-standing goiter and hypothyroidism: An unusual presentation of a TSH-secreting adenoma. Thyroid. DOI
• Benard, F., Lefebvre, B., Beuvon, F., Langlois, M.-F., Bisson, G. (1995). Rapid washout of technetium-99m-MIBI from a large parathyroid adenoma. Journal of Nuclear Medicine.

Articles de conférence

• Leboeuf, R., Langlois, M.-F., Martin, M., Ahnadi, C.E., Fink, G.D. (2006). Clinical case seminar - "Hook effect" in calcitonin immunoradiometric assay in patients with metastatic medullary thyroid carcinoma: Case report and review of the literature. Journal of Clinical Endocrinology and Metabolism. DOI
• Bellabarba, D., Langlois, M.-F., Carpentier, A. (1995). Consensus and controversy on the treatment of differentiated thyroid carcinoma,CONSENSUS ET CONTROVERSE AU SUJET DU TRAITEMENT DES CANCERS THYROIDIENS DIFFERENCIES. Annales D Endocrinologie.